VERU INC. Deferred Tax Liabilities, Intangible Assets
VERU INC. (VERU) had Deferred Tax Liabilities, Intangible Assets of $0 as of 2024-09-30, per its 10-K filed 2024-12-16.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets · last filed 2024-12-16
- 2024-09-30: Deferred Tax Liabilities, Intangible Assets $0.00.
- 2023-09-30: Deferred Tax Liabilities, Intangible Assets $1.35K.
- 2023-03-31: Deferred Tax Liabilities, Intangible Assets $9.43K.
- 2022-12-31: Deferred Tax Liabilities, Intangible Assets $13.47K.
| Period end | Deferred Tax Liabilities, Intangible Assets |
|---|---|
| 2024-09-30 | $0.00 10-K · filed 2024-12-16 |
| 2023-09-30 | $1.35K 10-K · filed 2024-12-16 |
| 2023-03-31 | $9.43K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $13.47K 10-Q · filed 2023-02-09 |
| 2022-09-30 | $17.51K 10-K/A · filed 2024-04-01 |
| 2022-06-30 | $21.55K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $25.59K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $29.63K 10-Q · filed 2022-02-09 |
| 2021-09-30 | $33.67K 10-K · filed 2022-12-05 |
| 2021-06-30 | $37.71K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $41.75K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $45.79K 10-Q · filed 2021-02-10 |
| 2020-09-30 | $49.83K 10-K · filed 2021-12-02 |
| 2020-06-30 | $53.87K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $57.91K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $61.95K 10-Q · filed 2020-02-12 |
| 2019-09-30 | $65.99K 10-K · filed 2020-12-10 |
| 2019-06-30 | $80.41K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $85.04K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $89.68K 10-Q · filed 2019-02-13 |
| 2018-09-30 | $94.32K 10-K · filed 2019-12-12 |
| 2018-06-30 | $99.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $101.00K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $106.00K 10-Q · filed 2018-02-14 |
| 2017-09-30 | $200.00K 10-K · filed 2018-12-13 |
| 2017-06-30 | $8.20M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $8.20M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $8.16M 10-Q · filed 2017-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |